Gladstone Institutional Advisory’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$854K Sell
7,057
-5
-0.1% -$605 0.04% 379
2025
Q1
$787K Buy
7,062
+85
+1% +$9.48K 0.04% 373
2024
Q4
$679K Sell
6,977
-190
-3% -$18.5K 0.03% 390
2024
Q3
$824K Sell
7,167
-105
-1% -$12.1K 0.04% 349
2024
Q2
$774K Buy
7,272
+597
+9% +$63.6K 0.04% 336
2024
Q1
$646K Sell
6,675
-1,215
-15% -$118K 0.04% 368
2023
Q4
$797K Sell
7,890
-212
-3% -$21.4K 0.04% 328
2023
Q3
$825K Sell
8,102
-65
-0.8% -$6.62K 0.05% 292
2023
Q2
$824K Sell
8,167
-64
-0.8% -$6.46K 0.05% 307
2023
Q1
$757K Buy
8,231
+119
+1% +$10.9K 0.05% 336
2022
Q4
$736K Buy
8,112
+89
+1% +$8.07K 0.05% 330
2022
Q3
$610K Buy
8,023
+67
+0.8% +$5.09K 0.05% 353
2022
Q2
$673K Sell
7,956
-1,294
-14% -$109K 0.05% 347
2022
Q1
$812K Sell
9,250
-2,224
-19% -$195K 0.05% 339
2021
Q4
$1M Sell
11,474
-3,093
-21% -$271K 0.08% 262
2021
Q3
$1.19M Buy
14,567
+6,458
+80% +$528K 0.12% 210
2021
Q2
$740K Buy
8,109
+3,713
+84% +$339K 0.09% 232
2021
Q1
$376K Buy
4,396
+551
+14% +$47.1K 0.06% 284
2020
Q4
$363K Sell
3,845
-450
-10% -$42.5K 0.07% 201
2020
Q3
$374K Buy
4,295
+219
+5% +$19.1K 0.09% 170
2020
Q2
$356K Sell
4,076
-453
-10% -$39.6K 0.09% 160
2020
Q1
$374K Sell
4,529
-498
-10% -$41.1K 0.1% 165
2019
Q4
$476K Sell
5,027
-701
-12% -$66.4K 0.12% 143
2019
Q3
$498K Buy
5,728
+3,265
+133% +$284K 0.13% 141
2019
Q2
$225K Buy
+2,463
New +$225K 0.07% 242